T2 biosystems stocktwits

T2 Biosystems GAAP EPS of -$0.08 beats b

T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic ...TTOO T2 Biosystems Inc 53,583 Watch Alerts $0.2026 $0.0155 (7.11%) Today About Feed News Sentiment Earnings Fundamentals Disclaimer: This is informational only. Learn more Sentiment Indicates whether most users posting on a symbol's stream over the last 24 hours are fearful or greedy. 0 25 50 75 100 Extreme Fear Neutral Greed Extreme Fear Greed N/A

Did you know?

Get the latest Jaguar Health Inc (JAGX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Oct 12, 2023 · T2 Biosystems to Report Second Quarter 2023 Financial Results on August 7, 2023. T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2023 after market close Monday, August 7, RHEA-AI. neutral. Jul 20, 2023 · T2 Biosystems ( NASDAQ: TTOO) has received breakthrough device status from the US Food and Drug Administration for its Candida auris molecular diagnostic blood test. The test is designed to detect ... LOS ANGELES, Oct. 13, 2023-- Southern California Gas Co. (SoCalGas) today issued the following statement in support of the U.S. Department of Energy's decision to award California up to $1.2 billion for a regional clean hydrogen hub [1].SoCalGas is a proud partner of the Alliance for Renewable Clean Hydrogen Energy Systems (ARCHES), the statewide public-private partnership and the organizer ...Oct 6, 2023 · Oct 2. CR Group discloses sale of 13M T2 Biosystems shares. Sep 28. CR Group discloses sale of another 250,000 T2 Biosystems shares. Sep 27. CR Group sells another $1.3M shares in T2 Biosystems, shares fall. Sep 26. T2 Biosystems investor CR Group sells $1.9M in common stock. Sep 26. T2 Biosystems Inc. (TTOO) experienced a significant drop in its stock performance on October 13, 2023. The stock opened at $10.47, which was much lower …Jul 12, 2023 · LEXINGTON, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced ... T2 Biosystems, Inc. (TTOO) NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Find the latest T2 Biosystems, Inc. (TTOO) stock discussion in Yahoo Finance's forum. Share your opinion and...Latest TTOO News. Get all financial information for T2 Biosystems Inc (TTOO) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week …Investment Thesis. Accelerate Diagnostics ( NASDAQ: AXDX) and T2 Biosystems ( NASDAQ: TTOO) are two companies focused on the same space - the diagnosis of serious blood infections, and most ...T2 will have its second quarter report out on Tuesday, August 11 after the bell, but already last month released its preliminary numbers -- and they look good: Estimated second quarter 2020 total revenue is expected to be in the range of $2.4 million to $2.6 million, compared to $1.8 million in the prior year period.T2 Biosystems shares are up more than 20% in early trading Friday, though the stock remains down 12% over the last five days. According to an SEC filing, CR Group L.P. sold another 5 million ...Aug 16, 2023 · T2 Biosystems is trading down on the day, however the stock remains up 54% over the last five days and up more than 375% over the last month. Shares of TTOO are moving on heavy trading volume ... Oct 9, 2023 · benzinga.com - September 25 at 1:25 PM. 10% Owner of T2 Biosystems Makes $3.81M Sale. benzinga.com - September 22 at 2:12 PM. T2 Biosystems stock falls again as diagnostics developer faces cash crunch (update) msn.com - September 22 at 1:03 AM. T2 Biosystems’ stock extends losing streak despite FDA approval for anthrax and plague diagnostic test. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!benzinga.com - September 25 at 1:25 PM. 10% Owner of T2 Biosystems Makes $3.81M Sale. benzinga.com - September 22 at 2:12 PM. T2 Biosystems stock falls again as diagnostics developer faces cash crunch (update) msn.com - September 22 at 1:03 AM. T2 Biosystems’ stock extends losing streak despite FDA approval for anthrax and plague diagnostic test.#TTOO #TTOOStock #TTOOStockAnalysis #TTOOStockPrediction #TTOOStocktwits #newyork #nasdaq #dowjones #nyseamericans #stocks #T2BiosystemsTTOO Stock - T2 Biosy...T2 Biosystems ( NASDAQ: TTOO) is a bygone favorite of mine that has bumped along on the fringes. I last discussed it in 08/2020's "COVID-19 Opportunity Knocks, T2 Answers". At the time, T2 was ...Shares of micro cap T2 Biosystems Inc. TTOO, +23.54% rose 14.3% in premarket trades Tuesday, continuing a rally that saw the stock end Monday’s session up 15.4%. The stock is on a two-day ...TTOO | Complete T2 Biosystems Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.https://www.t2biosystems.com. T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum ...

Get all financial information for T2 Biosystems Inc (TTOO) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high & 52 week low, Beta and much moreLEXINGTON, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards... T2 Biosystems to Participate in the Gilmartin Group Emerging Growth Company Showcase Globe Newswire • about 1 month agoThese incentives were on full display in T2 Biosystem’s latest financial filings. According to its latest quarter report, the number of TTOO shares outstanding jumped from 24,887,722 in May to ...T2 Biosystems will likely see a similar drawdown (at least without positive FDA news). The company is popular among retail traders, and a sudden price decrease will cause many to lose interest ...

And retail investor favorite T2 Biosystems fell sharply after announcing a 1-for-100 reverse stock split as it tries to maintain compliance with the Nasdaq’s minimum …T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023 - Yahoo Finance. T2 Biosystems, Inc. LEXINGTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pa...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. LEXINGTON, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- T2 Bio. Possible cause: Get the latest Citius Pharmaceuticals Inc (CTXR) real-time quote, historical per.

Aug 3, 2023 · T2 Biosystems stock is soaring for the second day in a row.; On Monday, the company announced that the Nasdaq exchange had given the company until Nov. 20 to meet two of its rules.; Owners of TTOO ... LEXINGTON, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards... T2 Biosystems to Participate in the Gilmartin Group Emerging Growth Company Showcase Globe Newswire • about 1 month agoT2 Biosystems ( NASDAQ: TTOO) has received breakthrough device status from the US Food and Drug Administration for its Candida auris molecular diagnostic blood test. The test is designed to detect ...

Get the latest NRX Pharmaceuticals Inc (NRXP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.T2 Biosystems, Inc. engages in the development of a proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables detection of pathogens, biomarkers, and other abnormalities in a range of unpurified patient sample types. The firm's products include the T2Dx Instrument, the T2Candida Panel, the T2Bacteria Panel ...T2 Biosystems, Inc. (NASDAQ: TTOO) has been attracting significant attention throughout the tail end of July and August as investors eagerly await news regarding the potential FDA approval of their Sepsis treatment. The company’s stock price has surged by an impressive 320%, sparking intense speculation about the possibility of …

Jul 12, 2023 · LEXINGTON, Mass., July 12, 2023 ( In 2014, Massachusetts-based T2 Biosystems (NASDAQ: TTOO) went public at $11 per share. Expectations were high for the young startup. Its sepsis-detecting products targeted a $20.3 billion ...T2 Biosystems, Inc. (TTOO) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 8.20 -9.20 (-52.87%) LEXINGTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE)Find real-time TTOO - T2 Biosystems Inc stock quotes, company pr T2 Biosystems, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022. Mar. 16. CI. Earnings Flash (TTOO) T2 BIOSYSTEMS Reports Q4 Revenue $5.5M, vs. Street Est of $5.4M. Mar. 13. MT. T2 Biosystems, Inc. Provides Revenue Guidance for the Full Year of 2023. Mar. 13. Stock Price Forecast. The 2 analysts offering T2 Biosystems, Inc. Company has Filed an Appeal and will Present a Plan to Regain Compliance. LEXINGTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the ... The only FDA-cleared multi-target biothreThe Company raised $18.5 million in net proceeds through ATM sales in T2 Biosystems, Inc. is an in vitro diagnostics company. It has 84.25%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -1.33M. -113.00%. Get the latest Aditxt Inc (ADTX) real-time ...T2 Biosystems (TTOO) shares were down 17% in morning trading Tuesday after soaring 64% on Monday amid news that the company had received FDA clearance for its T2Biothreat Panel. T2 Biosystems Stock Forecast, TTOO stock pri 141.43%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. 9.34M. 256.85%. Get the latest Volcon Inc (VLCN) real-time ... Discover T2 Biosystems Inc (TTOO) market and co[Based on 2 Wall Street analysts offering 12 month price targets fUnternehmensprofil. T2 Biosystems, Inc. ist e T2 Biosystems, an emerging leader in the field of in vitro diagnostics, is dedicated to saving lives and reducing the cost of healthcare by empowering clinicians to effectively treat patients faster than ever before. T2 Biosystems is focused on addressing critical unmet needs in healthcare starting with sepsis, one of the deadliest and most ...